Bank of New York Mellon’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-307,215
Closed -$5.53M 4196
2020
Q2
$5.53M Sell
307,215
-41,595
-12% -$748K ﹤0.01% 2161
2020
Q1
$2.49M Buy
348,810
+36,561
+12% +$261K ﹤0.01% 2444
2019
Q4
$7.46M Buy
312,249
+3,708
+1% +$88.6K ﹤0.01% 2140
2019
Q3
$8.28M Buy
308,541
+30,650
+11% +$822K ﹤0.01% 2023
2019
Q2
$7.54M Sell
277,891
-8,839
-3% -$240K ﹤0.01% 2124
2019
Q1
$9.95M Sell
286,730
-1,284
-0.4% -$44.6K ﹤0.01% 1975
2018
Q4
$5.62M Sell
288,014
-86,205
-23% -$1.68M ﹤0.01% 2211
2018
Q3
$9.96M Sell
374,219
-21,944
-6% -$584K ﹤0.01% 2029
2018
Q2
$15M Sell
396,163
-1,369
-0.3% -$51.7K ﹤0.01% 1778
2018
Q1
$13M Buy
397,532
+19,526
+5% +$638K ﹤0.01% 1849
2017
Q4
$18.4M Buy
378,006
+43,979
+13% +$2.14M ﹤0.01% 1614
2017
Q3
$18M Buy
334,027
+56,385
+20% +$3.05M 0.01% 1627
2017
Q2
$15.6M Buy
277,642
+26,919
+11% +$1.51M ﹤0.01% 1706
2017
Q1
$9.83M Buy
250,723
+18,211
+8% +$714K ﹤0.01% 1976
2016
Q4
$5.22M Buy
232,512
+9,609
+4% +$216K ﹤0.01% 2290
2016
Q3
$5.06M Sell
222,903
-30,738
-12% -$698K ﹤0.01% 2235
2016
Q2
$5.99M Buy
253,641
+3,692
+1% +$87.1K ﹤0.01% 2120
2016
Q1
$5.1M Sell
249,949
-45,367
-15% -$925K ﹤0.01% 2174
2015
Q4
$15.2M Buy
295,316
+29,675
+11% +$1.53M ﹤0.01% 1579
2015
Q3
$11.3M Buy
265,641
+1,368
+0.5% +$58.3K ﹤0.01% 1788
2015
Q2
$12M Buy
264,273
+13,955
+6% +$636K ﹤0.01% 1856
2015
Q1
$9.5M Buy
250,318
+26,523
+12% +$1.01M ﹤0.01% 1980
2014
Q4
$6.34M Sell
223,795
-6,027
-3% -$171K ﹤0.01% 2178
2014
Q3
$5.81M Buy
229,822
+42,393
+23% +$1.07M ﹤0.01% 2219
2014
Q2
$5.47M Buy
187,429
+84,768
+83% +$2.47M ﹤0.01% 2283
2014
Q1
$2.66M Buy
102,661
+3,538
+4% +$91.6K ﹤0.01% 2700
2013
Q4
$2.55M Buy
99,123
+57,116
+136% +$1.47M ﹤0.01% 2733
2013
Q3
$1.12M Sell
42,007
-5,449
-11% -$146K ﹤0.01% 3169
2013
Q2
$1.17M Buy
+47,456
New +$1.17M ﹤0.01% 3100